NCT03748186 · Interventional trial
Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers
Overall registry status Completed
Phase 1
Conditions Endometrial Cancer, Endometrioid Adenocarcinoma, Fallopian Tube Cancer, Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer, Primary Peritoneal Carcinoma
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory